A PILOT STUDY OF A STEROID SULPHATASE INHIBITOR (BN83495) IN PATIENTS WITH RASH DUE TO TREATMENT WITH AN ORAL EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR (EGFR-TKI) FOR NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Mileshkin, Linda [1 ]
Mccormack, Chris [1 ]
Michael, Michael [1 ]
Solomon, Ben [1 ]
Urban, Damien [1 ]
Link, Emma [1 ]
Cowan, Linda [1 ]
Zalcberg, John [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Div Canc Med, East Melbourne, Vic, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
rash; EGFR; NSCLC; supportive care;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.24-041
引用
收藏
页码：S1020 / S1020
页数：1
相关论文
共 50 条
  • [31] Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy
    Yun, Nicole K.
    Rouhani, Sherin J.
    Bestvina, Christine M.
    Ritz, Ethan M.
    Gilmore, Brendan A.
    Tarhoni, Imad
    Borgia, Jeffrey A.
    Batus, Marta
    Bonomi, Philip D.
    Fidler, Mary Jo
    CANCERS, 2021, 13 (06) : 1 - 15
  • [32] Outcomes of sequential epidermal growth factor receptor tyrosine (EGFR) tyrosine kinase inhibitor (TKI) therapy in patients with advanced non-small cell lung carcinoma (NSCLC)- a real-world institutional experience
    Ang, Y.
    Wong, R.
    Tan, C. S.
    Blanco, M. V.
    Huang, Y.
    Goh, B. C.
    Soo, R. A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] COST EFFECTIVENESS OF FIRST LINE TYROSINE KINASE INHIBITOR TREATMENT IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS: A MARKOV MODEL
    Borget, I
    Vergnenegre, A.
    Chouaid, C.
    VALUE IN HEALTH, 2011, 14 (07) : A454 - A454
  • [34] Efficacy and safety of epidermal growth factor receptor (EGFR) - Tyrosine kinase inhibitors (TKI) in elderly patients with EGFR mutation-positive non-small cell lung cancer (NSCLC)
    Takeyasu, Y.
    Goto, Y.
    Morita, R.
    Sato, J.
    Murakami, S.
    Horinouchi, H.
    Fujiwara, Y.
    Kanda, S.
    Yamamoto, N.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [35] CYTOKERATIN 19 FRAGMENT (CYFRA21-1) PREDICTS THE EFFICACY OF THE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR (EGFR-TKI) IN NON-SMALL-CELL LUNG CANCER (NSCLC) HARBORING EGFR MUTATION
    Tanaka, K.
    Hata, A.
    Kaji, R.
    Fujita, S.
    Takeshita, J.
    Matsumoto, T.
    Monden, K.
    Nagata, K.
    Nanjo, S.
    Otsuka, K.
    Tachikawa, R.
    Otsuka, K.
    Hayashi, M.
    Tomii, K.
    Katakami, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 137 - 138
  • [36] Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NSCLC) Treated with First-line EGFR-TKI
    Lin, Liping
    Zhao, Juanjuan
    Hu, Jiazhu
    Huang, Fuxi
    Han, Jianjun
    He, Yan
    Cao, Xiaolong
    JOURNAL OF CANCER, 2018, 9 (03): : 528 - 534
  • [37] CONSISTENT LOW DEGREE ANTAGONISM OF COMBINED EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITOR (EGFR-TKI) AND INDIVIDUAL CHEMOTHERAPEUTIC AGENTS IN NON-SMALL CELL LUNG CANCER (NSCLC) CELLS HARBORING SENSITIZING-EGFR MUTATIONS
    Tsai, Chun-Ming
    Chang, K. -T.
    Chiu, Chao-Hua
    Hsiao, Shih-Yin
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S733 - S734
  • [38] First analysis of a real-world study to explore the character and treatment outcome of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) on non-small cell lung cancer (NSCLC) with brain metastases (BM)
    Zhang, H.
    Liu, L.
    Zhang, C.
    Zhang, N.
    Su, H.
    Song, Y.
    Min, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S126 - S126
  • [39] PHASE I STUDY OF HM61713, A NOVEL EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTANT SELECTIVE INHIBITOR, IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS HAVING AN ACTIVATING EGFR MUTATION BUT FAILED TO PRIOR EGFR TYROSINE KINASE INHIBITOR (TKI) THERAPY
    Kim, Dong-Wan
    Kim, Sang-We
    Kim, Tae Min
    Lee, Se-Hoon
    Choi, Chang-Min
    Keam, Bhumsuk
    Lee, Jae Cheol
    Heo, Dae-Seog
    Lee, Jungshin
    Yu, Kyung-Sang
    Jang, In-Jin
    Lim, Kyung Joon
    Son, Jee-Woong
    Lee, Dae Ho
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S892 - S893
  • [40] Effects of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in EGFR-mutated non-small cell lung cancer
    Yang, Guangdie
    Yao, Yinan
    Zhou, Jianya
    Zhao, Qiong
    ONCOLOGY REPORTS, 2012, 27 (06) : 2066 - 2072
12345